ABSTRACT
Wheat is the staple food crop in temperate countries and increasingly consumed in developing countries, displacing traditional foods. However, wheat products are typically low in bioavailable iron and zinc, contributing to deficiencies in these micronutrients in countries where wheat is consumed as a staple food. Two factors contribute to the low contents of bioavailable iron and zinc in wheat: the low concentrations of these minerals in white flour, which is most widely consumed, and the presence of phytates in mineral-rich bran fractions. Although high zinc types of wheat have been developed by conventional plant breeding (biofortification), this approach has failed for iron. However, studies in wheat and other cereals have shown that transgenic (also known as genetically modified; GM) strategies can be used to increase the contents of iron and zinc in white flour, by converting the starchy endosperm tissue into a 'sink' for minerals. Although such strategies currently have low acceptability, greater understanding of the mechanisms which control the transport and deposition of iron and zinc in the developing grain should allow similar effects to be achieved by exploiting naturally induced genetic variation. When combined with conventional biofortification and innovative processing, this approach should provide increased mineral bioavailability in a range of wheat products, from white flour to wholemeal.
ABSTRACT
Inadequate intake of essential minerals such as iron and zinc is a public health concern in the UK, particularly for girls and young women. Approximately 30% and 50% of the zinc and iron, respectively, in the UK diet is provided by cereals. In wheat, most of the iron and zinc is contained within the aleurone cell layer; however, aleurone is removed during processing of wheat into white flour. While elemental iron powder is added back into white flour at the milling stage, there is no restoration of zinc. Elemental iron powder has very low bioavailability, and therefore, in our current Biotechnology and Biological Sciences Research Council Diet and Health Research Industry Club-funded project, we are investigating the potential use of aleurone as a bioavailable source of minerals that could be added to wheat-based foods. This work has relevance for the food industry and may establish the use of aleurone as a functional food ingredient for fortification of a range of cereal-based food products.
ABSTRACT
Despite the rapid pace of biomedical innovation, research and development (R&D) productivity in the pharmaceutical industry has not improved broadly. Increasingly, firms need to leverage new approaches to product development and commercial execution, while maintaining adaptability to rapid changes in the marketplace and in biomedical science. Firms are also seeking ways to capture some of the talent, infrastructure, and innovation that depends on federal R&D investment. As a result, a major transition to external innovation is taking place across the industry. One example of these external innovation initiatives is the Sanofi-MIT Partnership, which provided seed funding to MIT investigators to develop novel solutions and approaches in areas of interest to Sanofi. These projects were highly collaborative, with information and materials flowing both ways. The relatively small amount of funding and short time frame of the awards built an adaptable and flexible process to advance translational science.
Subject(s)
Biomedical Research/organization & administration , Diffusion of Innovation , Drug Industry/organization & administration , Universities/organization & administration , Cooperative Behavior , Efficiency, Organizational , Humans , Translational Research, Biomedical/organization & administrationABSTRACT
Cereals constitute important sources of iron in human diet; however, much of the iron in wheat is lost during processing for the production of white flour. This study employed novel food processing techniques to increase the bioaccessibility of naturally occurring iron in wheat. Iron was localized in wheat by Perl's Prussian blue staining. Soluble iron from digested wheat flour was measured by a ferrozine spectrophotometric assay. Iron bioaccessibility was determined using an in vitro simulated peptic-pancreatic digestion, followed by measurement of ferritin (a surrogate marker for iron absorption) in Caco-2 cells. Light microscopy revealed that iron in wheat was encapsulated in cells of the aleurone layer and remained intact after in vivo digestion and passage through the gastrointestinal tract. The solubility of iron in wholegrain wheat and in purified wheat aleurone increased significantly after enzymatic digestion with Driselase, and following mechanical disruption using micromilling. Furthermore, following in vitro simulated peptic-pancreatic digestion, iron bioaccessibility, measured as ferritin formation in Caco-2 cells, from micromilled aleurone flour was significantly higher (52%) than from whole aleurone flour. Taken together our data show that disruption of aleurone cell walls could increase iron bioaccessibility. Micromilled aleurone could provide an alternative strategy for iron fortification of cereal products.
Subject(s)
Food Handling/methods , Intestinal Mucosa/metabolism , Iron/metabolism , Triticum/chemistry , Biological Availability , Caco-2 Cells , Digestion , Flour/analysis , Humans , Models, Biological , Seeds/chemistry , Seeds/metabolism , Triticum/metabolismABSTRACT
Kras-induced non-small-cell lung adenocarcinoma is the major subtype of lung cancers and is associated with poor prognosis. Using a lung cancer mouse model that expresses a cre-mediated KrasG12D mutant, we identified a critical role for the cell surface molecule CD44 in mediating cell proliferation downstream of oncogenic Kras signaling. The deletion of CD44 attenuates lung adenocarcinoma formation and prolongs the survival of these mice. Mechanistically, CD44 is required for the activation of Kras-mediated signaling through the mitogen-activated protein kinase (MAPK) pathway and thus promotes tumor cell proliferation. Together, these results reveal an unrecognized role for CD44 in oncogenic Kras-induced lung adenocarcinoma and suggest that targeting CD44 could be an effective strategy for halting Kras-dependent carcinomas.
Subject(s)
Adenocarcinoma/genetics , Carcinoma, Non-Small-Cell Lung/genetics , Hyaluronan Receptors/metabolism , Lung Neoplasms/genetics , Proto-Oncogene Proteins p21(ras)/metabolism , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Animals , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Cell Proliferation , Disease Models, Animal , Gene Expression Regulation, Neoplastic/genetics , Humans , Hyaluronan Receptors/genetics , Lung Neoplasms/pathology , Mice , Mitogen-Activated Protein Kinases/metabolism , Molecular Targeted Therapy , Mutation , Proto-Oncogene Proteins p21(ras)/genetics , Signal TransductionABSTRACT
Octamer transcription factor-1 (Oct-1) has recently been shown to function as a stress sensor that promotes cell survival subsequent to DNA damage. Here, we show that the survival signal imparted by Oct-1 following exposure to ionizing radiation (IR) is dependent upon DNA-dependent protein kinase (DNA-PK)-dependent phosphorylation of a cluster of 13 specific ser/thr residues within the N-terminal transcriptional regulatory domain of Oct-1. Although IR treatment did not affect the recruitment of Oct-1 to the histone H2B promoter, the recruitment of RNA polymerase II, TATA-binding protein and histone H4 acetylation were strongly reduced, consistent with a decrease in Oct-1 transcriptional regulatory potential following IR exposure. Ser/Thr-Ala substitution of 13 sites present in Oct-1 transcriptional regulatory domain eliminated Oct-1 phosphorylation subsequent to IR exposure. Further, these substitutions prevented Oct-1 from rescuing the survival of IR-treated Oct-1-/- murine embryonic fibroblasts, providing a direct link between DNA-PK-dependent phosphorylation and the contribution of Oct-1 to cell survival. These results implicate Oct-1 as a primary effector in a DNA-PK-dependent cell survival pathway that is activated by double-stranded DNA breaks.
Subject(s)
Amino Acid Substitution , DNA Damage , DNA-Activated Protein Kinase/metabolism , Octamer Transcription Factor-1/genetics , 3T3 Cells , Amino Acid Sequence , Animals , Binding Sites , Blotting, Western , Cell Line , Cell Line, Tumor , Cell Survival/genetics , Cell Survival/radiation effects , Dose-Response Relationship, Radiation , Histones/genetics , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Octamer Transcription Factor-1/metabolism , Phosphorylation , Promoter Regions, Genetic/genetics , Protein Binding/radiation effects , Serine/genetics , Serine/metabolism , Threonine/genetics , Threonine/metabolism , TransfectionABSTRACT
BACKGROUND: Only 10% of dietary iron is absorbed in the duodenum which implies that 90% (approximately 9 mg day(-1)) reaches the lower small intestine and colon. Therefore the purpose of this study was to assess the iron transport capacity of the rat proximal colon and to determine whether iron absorption is regulated by changes in dietary iron content. MATERIALS AND METHODS: Rats were fed for 14 days on either iron adequate (44 mg Fe kg(-1) diet) or iron-deficient (< 0.5 mg Fe kg(-1) diet) diets. The 59Fe transport across the colonic epithelium and its subsequent appearance in the blood were measured in vivo. In separate studies the colon was excised and used to measure divalent metal transporter expression. RESULTS: Divalent metal transporter (DMT1) was expressed at the apical membrane of the surface epithelium in rat proximal colon. In animals fed an iron-deficient diet, DMT1 mRNA and protein expression were increased. This was accompanied by a significant increase in tissue 59Fe uptake. CONCLUSIONS: The proximal colon can absorb non-haem iron from the intestinal lumen. The purpose of this mechanism remains to be elucidated.
Subject(s)
Colon/metabolism , Iron, Dietary/pharmacokinetics , Animals , Biological Transport , Blotting, Western , Cation Transport Proteins/metabolism , Duodenum/metabolism , Heme , Intestinal Absorption , Intestinal Mucosa/metabolism , Iron/blood , Iron Deficiencies , Iron, Dietary/administration & dosage , Iron-Binding Proteins/metabolism , Male , Rats , Rats, WistarABSTRACT
microRNAs (miRNAs) represent a large set of master regulators of gene expression. They constitute 1-4% of human genes and probably regulate 30% of protein-encoding genes. These small regulatory RNAs act at a posttranscriptional level-mediating translational repression and/or mRNA degradation-through their association with Argonaute protein and target mRNAs. In this paper, we discuss various mechanisms by which miRNAs regulate posttranscriptionally, including their subcellular localization. Recent results indicate that the majority of miRNA-targeted and thus translationally repressed mRNA is probably distributed in the diffuse cytoplasm, even though a small fraction is concentrated in subcellular compartments, such as processing bodies or stress granules; notably, the stress granule localization of Argonaute depends on the presence of miRNAs. Here we discuss the structural requirement of these subcellular compartments in light of their potential miRNA functions.
Subject(s)
MicroRNAs/genetics , MicroRNAs/metabolism , Animals , Humans , Mammals , Models, Biological , Protein Biosynthesis , RNA Processing, Post-Transcriptional , RNA Stability , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Subcellular Fractions/metabolismSubject(s)
Gene Silencing , RNA/metabolism , Animals , Biological Evolution , Codon, Nonsense , DNA Methylation , DNA Transposable Elements , RNA/biosynthesis , RNA/genetics , RNA Helicases/metabolism , RNA, Double-Stranded/biosynthesis , RNA, Double-Stranded/genetics , RNA, Double-Stranded/metabolism , RNA-Dependent RNA Polymerase/metabolismABSTRACT
In vitro selection was used to sample SnRNA-related sequences for ribozyme activities, and several 2',5'-branch-forming ribozymes were isolated. One such ribozyme is highly dependent upon an 11-nt motif that contains a conserved U6 snRNA sequence (ACAGAGA-box) known to be important for pre-mRNA splicing. The ribozyme reaction is similar to the first step of splicing in that an internal 2'-hydroxyl of an unpaired adenosine attacks at the 5'-phosphate of a guanosine. It differs in that the leaving group is diphosphate rather than a 5' exon. The finding that lariat formation can be accomplished by a small RNA with sequences related to U6 snRNA indicates that the RNA available in the spliceosome may be involved in RNA-catalyzed branch formation.
Subject(s)
Genetic Variation , RNA Precursors/genetics , RNA, Catalytic/metabolism , RNA, Small Nuclear/genetics , Animals , Base Sequence , Conserved Sequence , Exons , Gene Library , Introns , Kinetics , Molecular Sequence Data , Nucleic Acid Conformation , Oligodeoxyribonucleotides , Phylogeny , RNA Precursors/chemistry , RNA Precursors/metabolism , RNA Splicing , Saccharomyces cerevisiae/genetics , Sequence Alignment , Sequence Homology, Nucleic Acid , Substrate Specificity , Trypanosomatina/geneticsABSTRACT
The CDK9-cyclin T kinase complex, positive transcription elongation factor b (P-TEFb), stimulates the process of elongation of RNA polymerase (Pol) II during transcription of human immunodeficiency virus. P-TEFb associates with the human immunodeficiency virus Tat protein and with the transactivation response element to form a specific complex, thereby mediating efficient elongation. Here, we show that P-TEFb preferentially phosphorylates hSPT5 as compared with the carboxyl-terminal domain of RNA Pol II in vitro. Phosphorylation of hSPT5 by P-TEFb occurred on threonine and serine residues in its carboxyl-terminal repeat domains. In addition, we provide several lines of evidence that P-TEFb is a CDK-activating kinase (CAK)-independent kinase. For example, CDK9 was not phosphorylated by CAK, whereas CDK2-cyclin A kinase activity was dramatically enhanced by CAK. Therefore, it is likely that P-TEFb participates in regulation of elongation by RNA Pol II by phosphorylation of its substrates, hSPT5 and the CTD of RNA Pol II, in a CAK-independent manner.
Subject(s)
Chromosomal Proteins, Non-Histone , Fungal Proteins/metabolism , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , RNA Polymerase II/metabolism , Transcription Factors/metabolism , Transcriptional Elongation Factors , Base Sequence , DNA Primers , Phosphorylation , Positive Transcriptional Elongation Factor B , RNA Polymerase II/chemistryABSTRACT
Lactate and ammonia are the two major waste products formed during mammalian cell growth. Accumulation of these side products can have a negative effect on cell growth, and has drawn recent attention because of their inhibitory effects on the specific product synthesis rate. Our aim is to reduce lactate formation in the cell culture by genetically manipulating of the pathway of lactate synthesis with an aim to achieve high monoclonal antibody production. We have partially disrupted the LDH-A gene by homologous recombination in hybridoma cells (ATCC-CRL-1606). The cells that received the newly introduced DNA were selected by G418, and an LDH-deficient cell was identified by a screening method based on medium color changing in 96-well plates. A variant cell, LDH-neo21, was identified through this screening method and was characterized. The specific productivity of lactate by LDH-neo21 cells was 50% lower than that of parental cells. Intracellular LDH enzyme activity was significantly reduced. The cell growth was improved both in terms of cell density and cell viability. Total cell density potentially reached 5 x 10(6) cells/mL while the parental hybridoma cells had a cell density of 3.5 x 10(6) cells/mL, which represented a 30% increase. The antibody production of LDH-neo21 cells was threefold greater than that of parental cells during 5-day batch culture. Polymerase chain reaction (PCR) results showed that at least one copy of the LDH-A gene was disrupted in the LDH-neo21 cells. The variant of the hybridoma cell exhibited a significant advantage of reduced lactate formation in the cell culture with a high concentration of glucose, which led to a higher production of monoclonal antibody. 2001 John Wiley & Sons, Inc.
Subject(s)
Antibodies, Monoclonal/genetics , Genetic Engineering/methods , L-Lactate Dehydrogenase/genetics , Lactates/metabolism , Ammonia/metabolism , Animals , Antibodies, Monoclonal/biosynthesis , Cell Division , DNA/genetics , Genetic Vectors , Hybridomas , L-Lactate Dehydrogenase/metabolism , Mammals , Mice , Polymerase Chain Reaction/methods , Recombinant Proteins/biosynthesis , Transfection/methodsABSTRACT
Microscopy studies have shown that XIST RNA colocalizes with the inactive X chromosome (Xi). However, the molecular basis for this colocalization is unknown. Here we provide two lines of evidence from chromatin immunoprecipitation experiments that XIST RNA physically associates with the Xi chromatin. First, XIST RNA can be co-precipitated by antiserum against macroH2A, a histone H2A variant enriched in the Xi. Second, XIST RNA can be co-precipitated by antisera that recognize unacetylated, but not acetylated, isoforms of histones H3 and H4. The specificity of XIST RNA association with hypoacetylated chromatin, together with the previous finding that hypoacetylated histone H4 is enriched at promoters of X-inactivated genes, raises the possibility that XIST RNA may contribute to the hypoacetylation of specific regions of the Xi so as to alter the expression of X-linked genes.
Subject(s)
RNA, Untranslated/genetics , Transcription Factors/genetics , X Chromosome , Animals , Antibody Specificity , Cells, Cultured , Chromatin/chemistry , Dosage Compensation, Genetic , Fibronectins/genetics , Histones/genetics , Immune Sera , Mice , Promoter Regions, Genetic , RNA, Long Noncoding , RNA, Untranslated/immunology , Transcription Factors/immunologyABSTRACT
Double-stranded RNA (dsRNA) directs the sequence-specific degradation of mRNA through a process known as RNA interference (RNAi). Using a recently developed Drosophila in vitro system, we examined the molecular mechanism underlying RNAi. We find that RNAi is ATP dependent yet uncoupled from mRNA translation. During the RNAi reaction, both strands of the dsRNA are processed to RNA segments 21-23 nucleotides in length. Processing of the dsRNA to the small RNA fragments does not require the targeted mRNA. The mRNA is cleaved only within the region of identity with the dsRNA. Cleavage occurs at sites 21-23 nucleotides apart, the same interval observed for the dsRNA itself, suggesting that the 21-23 nucleotide fragments from the dsRNA are guiding mRNA cleavage.
Subject(s)
Adenosine Triphosphate/metabolism , RNA, Antisense/metabolism , RNA, Double-Stranded/metabolism , RNA, Messenger/metabolism , Animals , Base Sequence , Binding Sites , Drosophila/embryology , Drosophila/genetics , Molecular Sequence Data , Nucleotides , Protein Biosynthesis , RNA Processing, Post-Transcriptional , RNA, Small InterferingABSTRACT
Host cell factor 1 (HCF-1; also called C1) is a 230-kDa protein which is cleaved posttranslationally into separate but associated N- and C-terminal polypeptides. These polypeptides are components of the C1 complex, along with Oct-1 and the viral protein VP16. The C1 complex is formed when herpes simplex virus (HSV) infects a cell and is responsible for transcription of the HSV immediate-early genes. A temperature-sensitive mutation in the N-terminal kelch domain of HCF-1 reversibly arrests cells in a G(0)-like state when grown at the nonpermissive temperature, and the same domain interacts with VP16 in the formation of the C1 complex. The form of HCF-1 in primary G(0) cells was investigated by using peripheral blood mononucleocytes and serum-arrested human primary fibroblasts. A novel 50-kDa N-terminal fragment of HCF-1 encompassing the kelch domain was identified in the cytoplasm of these cells. This fragment arises by proteolysis of the full-length HCF-1 protein and is able to associate with VP16.
Subject(s)
Herpes Simplex Virus Protein Vmw65/metabolism , Peptide Fragments/metabolism , Proteins/metabolism , Resting Phase, Cell Cycle/physiology , Carrier Proteins , DNA-Binding Proteins/metabolism , Fibroblasts/cytology , Host Cell Factor C1 , Humans , Leukocytes, Mononuclear/cytology , Octamer Transcription Factor-1 , Protein Binding , Protein Structure, Tertiary , Simplexvirus , Transcription Factors/metabolism , Virus LatencySubject(s)
Caenorhabditis elegans Proteins , Caenorhabditis elegans/genetics , DNA Transposable Elements , Gene Expression Regulation , Gene Silencing , RNA, Double-Stranded/genetics , RNA, Helminth/genetics , RNA, Messenger/genetics , Animals , Female , Genes, Helminth , Helminth Proteins/genetics , Helminth Proteins/physiology , Male , Mutation , RNA, Helminth/metabolism , RNA, Messenger/metabolismABSTRACT
The SRm160/300 splicing coactivator, which consists of the serine/arginine (SR)-related nuclear matrix protein of 160 kDa and a 300-kDa nuclear matrix antigen, functions in splicing by promoting critical interactions between splicing factors bound to pre-mRNA, including snRNPs and SR family proteins. In this article we report the isolation of a cDNA encoding the 300-kDa antigen and investigate the activity of it and SRm160 in splicing. Like SRm160, the 300-kDa antigen contains domains rich in alternating S and R residues but lacks an RNA recognition motif; the protein is accordingly named "SRm300." SRm300 also contains a novel and highly conserved N-terminal domain, several unique repeated motifs rich in S, R, and proline residues, and two very long polyserine tracts. Surprisingly, specific depletion of SRm300 does not prevent the splicing of pre-mRNAs shown previously to require SRm160/300. Addition of recombinant SRm160 alone to SRm160/300-depleted reactions specifically activates splicing. The results indicate that SRm160 may be the more critical component of the SRm160/300 coactivator in the splicing of SRm160/300-dependent pre-mRNAs.
Subject(s)
Antigens, Nuclear , Nuclear Matrix-Associated Proteins , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , RNA Splicing/genetics , RNA-Binding Proteins/metabolism , Amino Acid Sequence , Antibodies, Monoclonal , Cell Nucleus/metabolism , Cells, Cultured , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , DNA, Complementary/metabolism , Humans , Molecular Sequence Data , Nuclear Proteins/immunology , Precipitin Tests , RNA Splicing/physiology , RNA, Messenger/metabolism , Spliceosomes/metabolismABSTRACT
As we contemplate the nature of life sciences in the 21st century, we should briefly consider the changes that have occurred in the past century. Surely, the sources of progress of this science in the next century are the advances emerging now. Furthermore, the likely pace of discovery and change in life sciences in the next century can best be estimated by a reflection on its history.
Subject(s)
Biological Science Disciplines/trends , Animals , Forecasting , HumansABSTRACT
Targeted disruption of either of the B cell-specific transcription factors Oct-2 or OCA-B/BOB-1/OBF-1 dramatically affects B cell terminal differentiation. The 3' enhancer of immunoglobulin heavy chain (IgH) locus is important for transcription of the locus in terminal plasma cells. Allele-specific suppression of mutant Oct-2 binding sites in this enhancer by a variant Oct-2 protein revealed that in a mature B cell line this enhancer was specifically dependent upon Oct-2, as contrasted to the closely related Oct-1 transcription factor. Phosphorylation of the Oct-2 protein was important for this activation and was synergistic for coactivation by the OCA-B factor. These results indicate that Oct-2 and OCA-B interact with the 3' enhancer in regulation of the IgH locus during B cell activation.